Neurorubine – Medicinal Product Register of Latvia

Cyanocobalaminum, Thiamini hydrochloridum, Pyridoxini hydrochloridum

Search by the name of the active substance

Return to the results

Medicinal product name

Neurorubine solution for injection

Pharmaceutical form

Solution for injection

Strength

Information from the MAH on shortages

No information on expected shortages

Availability of medicinal product

Product No.	Package size	Wholesalers' stock state
97-0291-02	N5	Is available
97-0291-05	N25	Is available

Legal status

Rx Prescription (Pr.)

Summary of product characteristics

03-11-2020

Package leaflet

17-06-2021

ATC code

A11DB – Vitamins

Medicinal products (4)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Is available (according to the information provided by wholesalers) (3193 containers)	Tamro, Magnum Medical, Recipe Plus, Baltfarm "Vita-Farm", Euroaptieka, Jelgavfarm, Oribalt Rīga, Elpis, Medelens+	N5 (3 ml)	Brown glass ampoule	€ 7.82	97-0291-02	Labelling text Nov 3, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N100 (3 ml)	Brown glass ampoule	€ 103.62	97-0291-03	Labelling text Nov 3, 2020
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N10 (3 ml)	Brown glass ampoule		97-0291-04	Labelling text Nov 3, 2020
Is available (according to the information provided by wholesalers) (287 containers)	Magnum Medical, Recipe Plus, Baltfarm "Vita-Farm", Jelgavfarm, Oribalt Rīga	N25 (3 ml)	Brown glass ampoule	€ 35.50	97-0291-05	Labelling text Nov 3, 2020

Registration information

Marketing authorisation No.	97-0291
Date of authorisation	Jul 2, 1997
Marketing authorisation holder, country	Teva B.V., Netherlands

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 18, 2024.